Ergomed in brief
Ergomed is a listed company in the Biotechnology industry, based in the UK. It was founded in 1997. Its last known market value was $711 M (July 2023); there is no current figure. In the year to Dec 2022 it had sales of $186 M and a net profit of $19 M, about 10 cents of profit for every dollar of sales. Its shares trade under the symbol ERGO.L (LSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Ergomed timeline
- 1997
- 🏁· approximateFounded
Events of Ergomed from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in UK: #404 (Jan 2020) · #461 (Jan 2021) · #472 (Jan 2022) · #349 (Dec 2022) · #386 (Jul 2023)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 10.2%
- Operating margin
- 14.0%
- Return on equity
- 17.4%
- Liabilities / assets
- 34.3%
Annual results
- Revenue
- $186 M
- Operating income
- $26 M
- Net income
- $19 M
Dec-2022 ending year
Balance sheet
- Total assets
- $166 M
- Total liabilities
- $57 M
- Total equity
- $109 M
Dec-2022 ending year
How Ergomed compares in Biotechnology
- Revenue$186 M · higher than 76% of 647
- Net margin10.2% · higher than 78% of 408
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Ergomed🇬🇧 | $711 M | — | 10.2% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Annual results:
- Dec-2022 ending year
- Balance sheet:
- Dec-2022 ending year
- Profile updated:
- Nov 4, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Ergomed? Verify and update this profile — free
Show Ergomed's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.